Cargando…
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone card...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098463/ https://www.ncbi.nlm.nih.gov/pubmed/32265828 http://dx.doi.org/10.3389/fneur.2020.00192 |
_version_ | 1783511185028546560 |
---|---|
author | Alì, Marco Monti, Caterina Beatrice Melazzini, Luca Cardani, Rosanna Fossati, Barbara Cavalli, Michele Chow, Kelvin Secchi, Francesco Meola, Giovanni Sardanelli, Francesco |
author_facet | Alì, Marco Monti, Caterina Beatrice Melazzini, Luca Cardani, Rosanna Fossati, Barbara Cavalli, Michele Chow, Kelvin Secchi, Francesco Meola, Giovanni Sardanelli, Francesco |
author_sort | Alì, Marco |
collection | PubMed |
description | Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone cardiac magnetic resonance at our center. Patients were age- and sex-matched with healthy controls. The Mann-Whitney U test was used to compare cardiac strain between the two groups. The t-test was used to compare the extracellular volume obtained in DM1 patients with that in healthy subject. Spearman's ρ was used for studying the associations among imaging parameters. Results: Global cardiac strain (median −19.1%; IQR −20.5%, −16.5%) in DM1 patients was lower (p = 0.011) than that in controls (median−21.7%; IQR−22.7%,-21.3%). Global extracellular volume in DM1 patients (median 32.3%; IQR 29.3%,36.8%) was significantly (p = 0.008) higher than that reported in literature in healthy subjects (median 25.6%; IQR 19.9%,31.9%). Global cardiac strain showed a strong, positive correlation with septal strain (ρ = 0.767, p = 0.016) and with both global (ρ = 0.733 p = 0.025) and septal extracellular volume (ρ = 0.767, p = 0.016). Discussion: The increase in cardiac extracellular volume and decrease in strain are signs of early cardiac pathology in DM1. Physicians dealing with DM1 may take into consideration cardiac magnetic resonance as a screening tool to identify early cardiac involvement in this condition. |
format | Online Article Text |
id | pubmed-7098463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70984632020-04-07 Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 Alì, Marco Monti, Caterina Beatrice Melazzini, Luca Cardani, Rosanna Fossati, Barbara Cavalli, Michele Chow, Kelvin Secchi, Francesco Meola, Giovanni Sardanelli, Francesco Front Neurol Neurology Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone cardiac magnetic resonance at our center. Patients were age- and sex-matched with healthy controls. The Mann-Whitney U test was used to compare cardiac strain between the two groups. The t-test was used to compare the extracellular volume obtained in DM1 patients with that in healthy subject. Spearman's ρ was used for studying the associations among imaging parameters. Results: Global cardiac strain (median −19.1%; IQR −20.5%, −16.5%) in DM1 patients was lower (p = 0.011) than that in controls (median−21.7%; IQR−22.7%,-21.3%). Global extracellular volume in DM1 patients (median 32.3%; IQR 29.3%,36.8%) was significantly (p = 0.008) higher than that reported in literature in healthy subjects (median 25.6%; IQR 19.9%,31.9%). Global cardiac strain showed a strong, positive correlation with septal strain (ρ = 0.767, p = 0.016) and with both global (ρ = 0.733 p = 0.025) and septal extracellular volume (ρ = 0.767, p = 0.016). Discussion: The increase in cardiac extracellular volume and decrease in strain are signs of early cardiac pathology in DM1. Physicians dealing with DM1 may take into consideration cardiac magnetic resonance as a screening tool to identify early cardiac involvement in this condition. Frontiers Media S.A. 2020-03-19 /pmc/articles/PMC7098463/ /pubmed/32265828 http://dx.doi.org/10.3389/fneur.2020.00192 Text en Copyright © 2020 Alì, Monti, Melazzini, Cardani, Fossati, Cavalli, Chow, Secchi, Meola and Sardanelli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Alì, Marco Monti, Caterina Beatrice Melazzini, Luca Cardani, Rosanna Fossati, Barbara Cavalli, Michele Chow, Kelvin Secchi, Francesco Meola, Giovanni Sardanelli, Francesco Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 |
title | Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 |
title_full | Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 |
title_fullStr | Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 |
title_full_unstemmed | Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 |
title_short | Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 |
title_sort | rare disease: cardiac risk assessment with mri in patients with myotonic dystrophy type 1 |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098463/ https://www.ncbi.nlm.nih.gov/pubmed/32265828 http://dx.doi.org/10.3389/fneur.2020.00192 |
work_keys_str_mv | AT alimarco rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT monticaterinabeatrice rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT melazziniluca rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT cardanirosanna rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT fossatibarbara rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT cavallimichele rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT chowkelvin rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT secchifrancesco rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT meolagiovanni rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 AT sardanellifrancesco rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1 |